Early detection of reduced bone formation with an NMR scanner
A method for early detection of bone deficiency in a patient, comprising: collecting NMR signals of a bone marrow volume in a bone of the patient having normal bone density levels which are not indicative of bone deficiency as indicated by X-ray; and analyzing said collected NMR signals to detect at least a presence or absence of a preclinical stage of bone deficiency in said bone.
1. A method for monitoring treatment of bone deficiency in a patient, comprising:
collecting NMR signals of a bone marrow volume in a bone of the patient, at a first time point, using a stray field non-homogeneous NMR scanner;
repeating the collecting of NMR signals at least at a second time point, at least six weeks after the first time point;
the patient receiving a treatment for bone deficiency, between the first time point and the second time point;
analyzing the NMR signals collected at the first time point and the second time point, comprising estimating one or both of adipose tissue content and changes in adipose tissue content of the bone marrow, providing feedback on the treatment.
2. The method according to claim 1 , wherein the bone of the patient has normal bone density levels which are not indicative of bone deficiency as indicated by X-ray.
3. The method according to claim 1 , wherein said analyzing comprises extracting, from said collected NMR signals, at least one parameter out of: T1 relaxation time, T2 relaxation time, T2* relaxation time, and apparent diffusion coefficient.
4. The method according to claim 1 , wherein said adipose tissue content comprises at least one of a volume fraction of adipocytes and a population of adipocytes in said bone marrow volume.
5. The method according to claim 1 , wherein estimating comprises using one or both of a ratio between T1 and T2 and a ratio between T1 and T2* to indicate changes in adipose tissue content.
6. The method according to claim 1 , wherein repeating the collecting of NMR signals is done also at one or more additional time points, and the method also comprises analyzing the NMR signals collected at the additional time points, providing additional feedback on the treatment.
7. The method according to claim 1 , wherein said method is performed without applying imaging pulses to said bone marrow volume.
8. The method according to claim 1 , wherein collecting the NMR signals the second time is done before changes in bone density in response to said treatment can be detected using X-ray.
9. The method according to claim 1 , wherein said treatment is in the form of one or more of use of pharmaceutical agents, a dietary change, and a change in physical activity.
10. The method according to claim 1 , further comprising performing a scout scan of said bone to locate said bone marrow volume.
11. The method according to claim 1 , wherein said analyzing comprises performing at least one of a one dimensional and multi-dimensional analysis of one or more of T1 relaxation time, T2 relaxation time, T2* relaxation time, and ADC, extracted from said collected NMR signals.
12. A method for monitoring treatment of bone deficiency in a patient, comprising:
collecting NMR signals of a bone marrow volume in a bone of the patient, at a first time point, without applying imaging pulses to the bone marrow volume;
repeating the collecting of NMR signals at least at a second time point, at least six weeks after the first time point;
the patient receiving a treatment for bone deficiency, between the first time point and the second time point;
analyzing the NMR signals collected at the first time point and the second time point, comprising estimating one or both of adipose tissue content and changes in adipose tissue content of the bone marrow, providing feedback on the treatment.
13. A method for monitoring treatment of bone deficiency in a patient, comprising:
collecting NMR signals of a bone marrow volume in a bone of the patient, at a first time point;
repeating the collecting of NMR signals at least at a second time point, at least six weeks after the first time point;
the patient receiving a treatment for bone deficiency, between the first time point and the second time point;
analyzing the NMR signals collected at the first time point and the second time point, comprising using one or both of a ratio between T1 and T2 and a ratio between T1 and T2* to indicate changes in adipose tissue content of the bone marrow, providing feedback on the treatment.